1EU SHD Coalition, European Union (n.d.): https://structuralheartdiseasecoalition.eu/where-we-are/european-union (retrieved April 12, 2023)
2EuroIntervention 2017;13:Z11-Z13
3Prevalence model by SHS AT CVC BD based on: [1] Durko et al. (2018), [2] Nkomo et al. (2006), [3] Population data U.S. and Europe, DGR (2019), and Global Data (201)
4Data from countries (DRG): LAAC: USA, Germany, Japan ; TAVI + TMV: USA, Colombia, Brazil, Mexico, Argentina, Germany, UK, Italy, Spain, France, Japan, Australia, China, India, South Korea (2023)
5Patient Story is fictitious; clinical images originate from multiple cases
6Based on Pubmed search results
7Within physical limits
8Dose reduction (based on phantom measurement) compared to conventional automatic exposure control, e.g. available with Artis Q, image quality is defined by contrast-to noise ratio
The product/feature and/or service offerings (mentioned herein) are not commercially available in all countries and/or for all modalities. Their future availability cannot be guaranteed.
Image courtesies:
Courtesy of Piedmont Healthcare, Atlanta, USA
Courtesy of Piedmont Healthcare, Atlanta, USA
Courtesy of Abbott Northwestern Hospital, Minneapolis MN, USA
Courtesy of 3mensio
Courtesy of University Medical Center Mainz, Germany
Courtesy of Rigshospitalet, Copenhagen University Hospital, Denmark (LUX Valve)
Courtesy of SLK Kliniken Heilbronn, Germany
Courtesy of University Medical Center Mainz, Germany
Courtesy of Rigshospitalet, Copenhagen University Hospital, Denmark, ARTIS Q.zen
Courtesy of the Minneapolis, Abbott Northwestern Hospital, Minneapolis MN USA